The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
By A. Berg, Terry P. Combs, Xueliang Du, M. Brownlee, P. Scherer. Nature Medicine, 2001
2,639 citations recorded by the source corpus.
Subfields: Epidemiology, Molecular Biology, Physiology
View Paper: https://www.semanticscholar.org/paper/ed6b77d80632c5089f2c547377401931b7c9a650
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- Haiming Cao
- H. Fang
- R. L. Judd
- P. Scherer
- Gerald I. Shulman
- P. Trayhurn
- Toshimasa Yamauchi
- Takashi Kadowaki
In Molecular Biology
In Physiology
Citations in the corpus
- Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction (2017, background): “This activation of the PI3K pathway activates Akt and its downstream targets, which in turn exhibits a biological response [45].”
- Adipose Tissue (2006, positive): “Similar observations can be made in vitro using primary hepatocytes exposed to varying levels of insulin in the presence or absence of adiponectin (21).”
- Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. (2003, background): “Other studies have demonstrated an improvement in hepatic insulin sensitivity (15), and the infusion of mice with adiponectin during a euglycemic clamp demonstrated that the hypoglycemic effect of this cytokine was attributable to a suppression of hepatic glucose production (39).”
- Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. (2006, background): “A clue comes from several laboratories independently reported the cloning of intelectin (36), endothelial lectin HL-1 (3), and intestinal lactoferrin receptor (35), whose protein sequences are identical to omentin.”
- Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M400373-JLR200 (2005, background): “Adiponectin has been shown to augment lipid oxidation in skeletal muscle and myocytes (8, 9) and to reduce hepatic glucose production in liver and hepatocytes (10, 11).”